Life Science Company News

Natera Announces Second Quarter 2021 Earnings Conference Call

AUSTIN, Texas, July 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2021, after the market close on August 5, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

Earnings Conference Call Information:





Event:          

Natera's Second Quarter 2021 Financial Results Conference Call





Date:             

Thursday, August 5, 2021





Time:              

1:30 p.m. PT (4:30 p.m. ET)





Live Dial-In:     

(877) 823-0171, Domestic

(617) 500-6932, International





Password:        

4434144





Webcast:        

https://edge.media-server.com/mmc/p/oe2yd2em

A webcast replay will be available at investor.natera.com.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350

Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com     

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-announces-second-quarter-2021-earnings-conference-call-301343978.html

SOURCE Natera, Inc.

By: PR Newswire Association LLC. - 29 Jul 2021
Back to overview

Enhance your business development with Biotechgate